Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals : The Hoorn Study
Objective: Hyperhomocysteinemia is a risk factor for atherothrombosis. Through unknown mechanisms, individuals with type 2 diabetes appear particularly susceptible. We determined whether components of homocysteine metabolism are associated with intima-media thickness in individuals with and without...
Saved in:
Published in | Atherosclerosis Vol. 169; no. 2; pp. 323 - 330 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ireland Ltd
01.08.2003
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective: Hyperhomocysteinemia is a risk factor for atherothrombosis. Through unknown mechanisms, individuals with type 2 diabetes appear particularly susceptible. We determined whether components of homocysteine metabolism are associated with intima-media thickness in individuals with and without type 2 diabetes.
Methods and results: In a cross-sectional design, we studied 231 Caucasian individuals, 60.6% having type 2 diabetes. We measured fasting homocysteine, vitamin B
6 and vitamin B
12 in plasma, and folate,
S-adenosylmethionine and
S-adenosylhomocysteine in plasma and erythrocytes. A homocysteine concentration >12 μmol/l was associated with a greater intima-media thickness of +0.07 mm (95% CI, +0.01 to +0.13;
P=0.03) among diabetic individuals and of −0.004 mm (95%CI, −0.08 to +0.07;
P=0.92) among non-diabetic individuals. An erythrocyte
S-adenosylmethionine concentration above >4000 nmol/l was associated with a smaller intima-media thickness of −0.04 mm (95%CI, −0.10 to +0.02;
P=0.17) for diabetic individuals versus −0.12 mm (95%CI, −0.20 to −0.36;
P=0.005) for non-diabetic individuals.
Conclusions: With regard to carotid intima-media thickness, individuals with diabetes appear more susceptible to the detrimental effects of homocysteine than non-diabetic individuals. In addition, diabetic individuals may lack the protective effect on the vascular wall conferred by high concentrations of
S-adenosylmethionine. These findings may help explain why hyperhomocysteinemia is an especially strong risk factor for atherothrombosis among individuals with type 2 diabetes. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-News-3 content type line 23 |
ISSN: | 0021-9150 1879-1484 |
DOI: | 10.1016/S0021-9150(03)00199-0 |